---

Honoring Scientific Leaders in Cancer Diagnostics and Leptomeningeal Metastases Innovation

On International Day of Women and Girls in Science, we are proud to recognize the exceptional women across the CNSide® Diagnostics and Plus Therapeutics teams who are helping shape the future of cancer diagnostics and treatment including innovative approaches toward leptomeningeal metastases.

Behind every advancement in science are passionate individuals dedicated to improving patient outcomes through innovation, collaboration, and relentless curiosity. At CNSide Diagnostics, our on-site laboratory team plays a critical role in advancing diagnostic solutions designed to support clinicians and patients facing rare and difficult-to-treat cancers, including leptomeningeal metastases (LM).

Today, we celebrate the talented women whose expertise, precision, and commitment help drive the continued advancement of CNSide — and whose work contributes to a larger global movement of women leading the future of science, medicine, and healthcare innovation.

---

The Importance of Women in Science and Diagnostics

Scientific innovation depends on diverse perspectives, experiences, and leadership. Women continue to make groundbreaking contributions across oncology, biotechnology, pathology, laboratory medicine, and diagnostics, helping accelerate progress in areas where patients urgently need new solutions.

In the field of cancer diagnostics, laboratory scientists are essential to delivering accurate, reliable, and clinically meaningful information that can help guide patient management. Their work requires a combination of technical expertise, analytical thinking, attention to detail, and compassion for the patients ultimately impacted by every sample processed.

At CNSide Diagnostics, we are fortunate to have an incredible team of women contributing across laboratory operations, research, quality assurance, clinical development, and innovation initiatives.

---

Advancing CNSide® Through Scientific Excellence

CNSide® is designed to provide enhanced detection and characterization of tumor cells in cerebrospinal fluid (CSF), helping address the challenges associated with diagnosing leptomeningeal metastases.

The development and continued advancement of CNSide would not be possible without the dedication of the scientists and laboratory professionals who work behind the scenes every day to uphold the highest standards of quality, accuracy, and innovation.

From processing patient samples and conducting complex analyses to supporting research initiatives and ensuring operational excellence, the women on our laboratory team are integral to our mission.

Their contributions help support:

• High-quality laboratory operations
• Scientific and clinical innovation
• Ongoing assay development and optimization
• Collaboration across multidisciplinary teams
• A patient-centered approach to diagnostic advancement

Every member of the team contributes to a shared goal: helping improve the diagnostic journey for patients facing serious neurologic cancers.

Discover how innovation, laboratory science, and CNSide® technology are helping reshape the future of LM diagnostics by filling out a contact form to speak to an expert.

---

About CNSide® Diagnostics

CNSide® is a proprietary diagnostic platform designed to detect and characterize tumor cells in cerebrospinal fluid (CSF) from patients with leptomeningeal metastases. The platform combines advanced technologies to support enhanced diagnostic insights and help address unmet needs in neuro-oncology.